# Vascular Function Intervention Trial in Sickle Cell Disease

> **NCT01718054** · PHASE2,PHASE3 · UNKNOWN · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 120 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Vascular ready-to-use supplementary food
- **DIETARY_SUPPLEMENT:** Regular Ready-to-use supplementary food
- **DRUG:** Chloroquine

## Key facts

- **NCT ID:** NCT01718054
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2016-09
- **Final completion:** 2017-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2016-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718054, "Vascular Function Intervention Trial in Sickle Cell Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01718054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*